Ozempic-like weight loss drug Mounjaro launched in India – Details

Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management. Approved by CDSCO, it targets GIP and GLP-1 receptors, aiming to improve blood sugar control and aid in weight loss. Clinical trials showed significant results, underlining its potential in treating diabetes and obesity.

​Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management. Approved by CDSCO, it targets GIP and GLP-1 receptors, aiming to improve blood sugar control and aid in weight loss. Clinical trials showed significant results, underlining its potential in treating diabetes and obesity.